Found 0 matching trials
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma PHASE2 Background:
One way to treat liver cancer is to deliver chemotherapy drugs...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain N/A Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Show More Learn More & Join Trial
Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study) N/A Develop a Metastatic Breast Cancer (MBC)-specific electronic Treatment Plan...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) N/A Patients with loco-regional NSCLC planned for curative treatment with chemo...
Show More Location
Odense University Hospital
Learn More & Join Trial
Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma PHASE4 The purpose of this study is to determine whether the rituximab administrat...
Show More Location
Hospital Infanta Cristina
Learn More & Join Trial
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma PHASE2 Currently, for further improved survival outcome, new cytotoxic compounds s...
Show More Location
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Learn More & Join Trial
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer PHASE2 RATIONALE: Pemetrexed disodium may stop the growth of tumor cells by blocki...
Show More Location
University of Michigan Comprehensive Cancer Center
Learn More & Join Trial
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Kaiser Franz Josef Hospital
Learn More & Join Trial